Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02018445 · ClinicalTrials.gov registry record · NA
Accell Evo3™ Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion
A NA study, sponsored by SeaSpine.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT02018445 is a NA study that has completed, run by SeaSpine. The registered enrollment target is 36 participants.
The verdict
NCT02018445, a NA study, has completed, sponsored by SeaSpine.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The objective of this study is to prospectively evaluate the performance of Integra Accell Evo3 Demineralized Bone Matrix as an adjunct for instrumented posterolateral spine fusion, as compared to local autograft.
Interventions
- PROCEDURE Posterolateral Fusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2013-11 |
| Est. Completion | 2017-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02018445
The ClinicalTrials.gov registry entry for NCT02018445 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SeaSpine, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Posterolateral Fusion is the first listed.
NCT02018445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02018445 about?
NCT02018445 is a clinical study titled "Accell Evo3™ Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion". The objective of this study is to prospectively evaluate the performance of Integra Accell Evo3 Demineralized Bone Matrix as an adjunct for instrumented posterolateral spine fusion, as compared to local autograft.
What is the current status of trial NCT02018445?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2013-11. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02018445?
The interventions under investigation include: Posterolateral Fusion (PROCEDURE).
Who is sponsoring clinical trial NCT02018445?
This trial is sponsored by SeaSpine, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.